WO2024209404 - RNA DELIVERY VEHICLE
National phase entry is expected:
Publication Number
WO/2024/209404
Publication Date
10.10.2024
International Application No.
PCT/IB2024/053321
International Filing Date
05.04.2024
Title **
[English]
RNA DELIVERY VEHICLE
[French]
VÉHICULE D'ADMINISTRATION D'ARN
Applicants **
SEQIRUS INC.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
Inventors
ROCKMAN, Steven
c/o Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
LAURIE, Karen Louise
c/o Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
MCMAHON, Meagan Kathleen
c/o Seqirus Inc
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
Priority Data
63/494,274
05.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1623 | |
| EPO | Filing, Examination | 10528 | |
| Japan | Filing | 535 | |
| South Korea | Filing | 576 | |
| USA | Filing, Examination | 3205 |
Total: 16467 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to an RNA delivery vehicle comprising lipid nanoparticles comprising the RNA therein, and a RNA-binding protein or peptide coated on the exterior surface of the lipid nanoparticle, and uses thereof.[French]
La présente invention concerne un véhicule d'administration d'ARN comprenant des nanoparticules lipidiques à l'intérieur desquelles l'ARN se trouve, et une protéine ou un peptide de liaison à l'ARN appliqué sur la surface extérieure de la nanoparticule lipidique, et ses utilisations.